Eric Floyd
Chairman at VIRPAX PHARMACEUTICALS, INC.
Net worth: 2 334 $ as of 30/04/2024
Eric Floyd active positions
Companies | Position | Start | End |
---|---|---|---|
VIRPAX PHARMACEUTICALS, INC. | Independent Dir/Board Member | 01/01/2017 | - |
Chairman | 20/11/2023 | - | |
Director/Board Member | 01/01/2017 | 20/11/2023 | |
SILENCE THERAPEUTICS PLC | General Counsel | 01/07/2020 | - |
Meharry Medical College | Director/Board Member | - | - |
Advent Therapeutics, Inc.
Advent Therapeutics, Inc. Medical SpecialtiesHealth Technology Advent Therapeutics, Inc. provides therapies for micro-orphan applications. It manufactures a product for curing a disorder in newborn infants in the ICU. The company is headquartered in Lumberville, PA. | Director/Board Member | - | - |
Career history of Eric Floyd
Former positions of Eric Floyd
Companies | Position | Start | End |
---|---|---|---|
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Founder | - | 01/12/2019 |
General Counsel | 01/11/2018 | 01/12/2019 | |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | General Counsel | 01/06/2017 | 01/12/2019 |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Director/Board Member | 01/04/2014 | 01/11/2016 |
Floyd Regulatory Strategic Consulting Group LLC | Chief Executive Officer | - | - |
Harvard Medical School | Corporate Officer/Principal | - | - |
░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Training of Eric Floyd
Tennessee State University | Graduate Degree |
St. Joseph's University | Masters Business Admin |
University of Illinois | Undergraduate Degree |
Meharry Medical College | Doctorate Degree |
Insead Business School | Masters Business Admin |
Statistics
International
United States | 16 |
Switzerland | 2 |
United Kingdom | 2 |
Operational
General Counsel | 6 |
Director/Board Member | 4 |
Masters Business Admin | 2 |
Sectoral
Health Technology | 10 |
Consumer Services | 7 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
NOVARTIS AG | Health Technology |
SILENCE THERAPEUTICS PLC | Commercial Services |
VIRPAX PHARMACEUTICALS, INC. | Health Technology |
Private companies | 9 |
---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The private company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Health Technology |
Eversana Life Science Services LLC
Eversana Life Science Services LLC Miscellaneous Commercial ServicesCommercial Services EVERSANA Life Science Services LLC engages in the provision of global services to the life science industry. It offers pricing, reimbursement and market access, global channel management, revenue management, and affordability programs. The company is headquartered in Milwaukee, WI. | Commercial Services |
Advent Therapeutics, Inc.
Advent Therapeutics, Inc. Medical SpecialtiesHealth Technology Advent Therapeutics, Inc. provides therapies for micro-orphan applications. It manufactures a product for curing a disorder in newborn infants in the ICU. The company is headquartered in Lumberville, PA. | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Health Technology |
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Health Technology |
Floyd Regulatory Strategic Consulting Group LLC |
- Stock Market
- Insiders
- Eric Floyd
- Experience